Abstract
Background/Objectives:
Neuropeptide Y (NPY) gene has been shown to have a critical role in the regulation of satiety, reproduction, central endocrine and cardiovascular systems. Among the primary functions associated with NPY are its acute effects on feeding behavior and energy expenditure. The aim of this study is to evaluate the relationship between obesity and NPY gene polymorphisms in a South Indian Population.
Subjects/Methods:
Three polymorphisms in NPY gene (Leu7Pro, Ser50Ser and A7735G) were analyzed in 263 individuals of an endogamous Kota population. On the basis of body mass index (BMI), they were divided into two groups. Associations were tested using logistic regression and haplotype analyses and linkage disequilibrium (LD).
Results:
There was no evidence of deviation from Hardy–Weinberg equilibrium. Logistic regression analysis did not reveal significant association with obesity and NPY single-nucleotide polymorphisms (SNPs) in the present study. All three SNPs were in weak LD with low r2 values. Haplotype analysis also did not yield significant association between NPY gene and obesity (global P=0.756).
Conclusions:
Our study did not validate the association between previously implicated SNPs in NPY gene and obesity in an Indian population. Population-specific validation of putative associations has far reaching implications for the future personal genomics medicine applications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahituv N, Kavaslar N, Schackwitz W, Ustaszewska A, Martin J, Hebert S et al. (2007). Medical sequencing at the extremes of human body mass. Am J Hum Genet 80, 779–791.
Baker E, Hort YJ, Ball H, Sutherland GR, Shine J, Herzog H (1995). Assignment of the human neuropeptide Y gene to chromosome 7p15.1 by nonisotopic in situ hybridization. Genomics 26, 163–164.
Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265.
Bell CG, Walley AJ, Froguel P (2005). The genetics of human obesity. Nat Rev Genet 6, 221–234.
Bhaskar LV, Thangaraj K, Shah AM, Pardhasaradhi G, Praveen Kumar K, Reddy AG et al. (2007). Allelic variation in the NPY gene in 14 Indian populations. J Hum Genet 52, 592–598.
Billington CJ, Briggs JE, Grace M, Levine AS (1991). Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 260, R321–R327.
Bray MS, Boerwinkle E, Hanis CL (2000). Sequence variation within the neuropeptide Y gene and obesity in Mexican Americans. Obes Res 8, 219–226.
Campbell CD, Lyon HN, Nemesh J, Drake JA, Tuomi T, Gaudet D et al. (2007). Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men. Diabetes 56, 1460–1467.
Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F et al. (1997). Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet 74, 374–379.
Ding B (2003). Distribution of the NPY 1128C allele frequency in different populations. J Neural Transm 110, 1199–1204.
Ding B, Kull B, Liu Z, Mottagui-Tabar S, Thonberg H, Gu HF et al. (2005). Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept 127, 45–53.
Duncan JS, Duncan EK, Schofield G (2009). Accuracy of body mass index (BMI) thresholds for predicting excess body fat in girls from five ethnicities. Asia Pac J Clin Nutr 18, 404–411.
Erickson JC, Clegg KE, Palmiter RD (1996a). Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415–421.
Erickson JC, Hollopeter G, Palmiter RD (1996b). Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274, 1704–1707.
Gidding SS, Bao W, Srinivasan SR, Berenson GS (1995). Effects of secular trends in obesity on coronary risk factors in children: the Bogalusa Heart Study. J Pediatr 127, 868–874.
Han SS, Heo NJ, Na KY, Chae DW, Kim YS, Kim S et al. (2009). Age- and gender-dependent correlations between body composition and chronic kidney disease. Am J Nephrol 31, 83–89.
Karvonen MK, Koulu M, Pesonen U, Uusitupa MI, Tammi A, Viikari J et al. (2000). Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. J Clin Endocrinol Metab 85, 1455–1460.
Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A et al. (1998). Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 4, 1434–1437.
Karvonen MK, Valkonen VP, Lakka TA, Salonen R, Koulu M, Pesonen U et al. (2001). Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis 159, 145–151.
Lev-Ran A (2001). Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev 17, 347–362.
Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M (2009). Rationale for redefining obesity in Asians. Ann Acad Med Singapore 38, 66–69.
Luke A (2009). Ethnicity and the BMI-body fat relationship. Br J Nutr 102, 485–487.
Ma J, Nordman S, Mollsten A, Falhammar H, Brismar K, Dahlquist G et al. (2007). Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations. Eur J Endocrinol 157, 641–645.
Mattevi VS, Zembrzuski VM, Hutz MH (2002). Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord 26, 1179–1185.
Minth CD, Bloom SR, Polak JM, Dixon JE (1984). Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci USA 81, 4577–4581.
Mitchell GC, Wang Q, Ramamoorthy P, Whim MD (2008). A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. J Neurosci 28: 14428–14434.
Movsesyan L, Tanko LB, Larsen PJ, Christiansen C, Svendsen OL (2003). Variations in percentage of body fat within different BMI groups in young, middle-aged and old women. Clin Physiol Funct Imaging 23, 130–133.
Mueller JC (2004). Linkage disequilibrium for different scales and applications. Brief Bioinform 5, 355–364.
Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M et al. (2000). Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab 85, 2266–2269.
Pesonen U (2008). NPY L7P polymorphism and metabolic diseases. Regul Pept 149: 51–55.
Pettersson-Fernholm K, Karvonen MK, Kallio J, Forsblom CM, Koulu M, Pesonen U et al. (2004). Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients. Diabetes Care 27, 503–509.
Pihlajamaki J, Karhapaa P, Vauhkonen I, Kekalainen P, Kareinen A, Viitanen L et al. (2003). The Leu7Pro polymorphism of the neuropeptide Y gene regulates free fatty acid metabolism. Metabolism 52, 643–646.
Salminen M, Lehtimaki T, Fan YM, Vahlberg T, Kivela SL (2008). Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD. Public Health Nutr 11, 1156–1162.
Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG (2000). Central nervous system control of food intake. Nature 404, 661–671.
Snyder EE, Walts B, Perusse L, Chagnon YC, Weisnagel SJ, Rankinen T et al. (2004). The human obesity gene map: the 2003 update. Obes Res 12, 369–439.
Tatemoto K (1982). Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79, 5485–5489.
Thangaraj K, Joshi MB, Reddy AG, Gupta NJ, Chakravarty B, Singh L (2002). CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations. J Androl 23, 815–818.
Tzeng JY, Wang CH, Kao JT, Hsiao CK (2006). Regression-based association analysis with clustered haplotypes through use of genotypes. Am J Hum Genet 78, 231–242.
Ukkola O, Kesaniemi YA (2007). Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects. Eur J Clin Nutr 61, 1102–1105.
van Rossum CT, Pijl H, Adan RA, Hoebee B, Seidell JC (2006). Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults. Int J Obes (Lond) 30, 1522–1528.
Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J et al. (2009). Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373, 1083–1096.
WHO (2000). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894, i–xii, 1–253.
Yang L, Scott KA, Hyun J, Tamashiro KL, Tray N, Moran TH et al. (2009). Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance. J Neurosci 29, 179–190.
Acknowledgements
This project was supported by the grant from the Department of Biotechnology, Government of India (grant no. BT/PR3607/SPD/09/261/2003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Contributors: VRR, KT and LS conceived and designed the study. LVKSB conducted field work, collected blood samples and performed the SNP genotyping and its analysis. KPK and GP participated in SNP genotyping. The paper was written by LVKSB and VRR. In addition, KT and LS actively contributed to discussion of the results of this paper. All authors read and approved the final paper.
Rights and permissions
About this article
Cite this article
Bhaskar, L., Thangaraj, K., Pardhasaradhi, G. et al. Neuropeptide Y gene polymorphisms are not associated with obesity in a South Indian population. Eur J Clin Nutr 64, 868–872 (2010). https://doi.org/10.1038/ejcn.2010.74
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.74
Keywords
This article is cited by
-
Genetics of obesity and its measures in India
Journal of Genetics (2018)
-
Obesity gene not for South Indians
Nature India (2010)